Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)

India · Delayed Price · Currency is INR

59.80

+0.31 (0.52%)

Feb 19, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharma	433.12M	504.22M	521.34M	597.03M	526.84M
Pharma Growth	-14.10%	-3.29%	-12.68%	13.32%	62.63%
Total	433.12M	504.22M	521.34M	597.03M	526.84M
Total Growth	-14.10%	-3.29%	-12.68%	13.32%	62.63%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	433.12M	504.22M	521.34M	597.03M	526.84M
India Growth	-14.10%	-3.29%	-12.68%	13.32%	62.63%
Total	433.12M	504.22M	521.34M	597.03M	526.84M
Total Growth	-14.10%	-3.29%	-12.68%	13.32%	62.63%

Source: S&P Global Market Intelligence.